<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Thoracic <z:hpo ids='HP_0004942'>aortic aneurysm</z:hpo> is a major health problem with multiple causes and potentially devastating consequences </plain></SENT>
<SENT sid="1" pm="."><plain>At present, no large randomized trial has shown that medical therapy can significantly slow or halt the progressive <z:mpath ids='MPATH_66'>dilatation</z:mpath> that eventually leads to dissection and rupture </plain></SENT>
<SENT sid="2" pm="."><plain>Surgical therapy, on the other hand, is very effective at preventing these feared complications </plain></SENT>
<SENT sid="3" pm="."><plain>A recent study suggested that angiotensin-receptor blocking agents slow the development of <z:hpo ids='HP_0002617'>aneurysm</z:hpo> <z:mpath ids='MPATH_66'>dilatation</z:mpath> in <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>The authors argue that because of the multiple possible causes of <z:hpo ids='HP_0002617'>aneurysm</z:hpo> formation and the potential downsides of therapy, the available evidence is not strong enough to suggest that <z:hpo ids='HP_0000001'>all</z:hpo> patients with thoracic <z:hpo ids='HP_0004942'>aortic aneurysm</z:hpo> should be treated with angiotensin-receptor blocking agents </plain></SENT>
</text></document>